Exemestane Research Overview
Aromasin 25mg Para Pharma contains exemestane, a steroidal aromatase inhibitor extensively studied for its irreversible binding to the aromatase enzyme. Exemestane functions as a suicide inhibitor, permanently deactivating CYP19A1 through covalent bonding mechanisms. This compound represents a distinct class from non-steroidal inhibitors, offering researchers unique pharmacological properties for comparative studies. Laboratory investigations frequently examine exemestane’s androgenic metabolite 17-hydroexemestane, which demonstrates weak androgenic activity in cellular assays. Research applications span endocrine disruption studies, breast cancer cell line investigations, and hormonal pathway modulation research. The compound’s oral bioavailability and tissue distribution patterns make it valuable for pharmacokinetic studies comparing different aromatase inhibition strategies.
Laboratory Research Applications
Researchers at Stroid UK Shop investigate exemestane across multiple experimental frameworks. Studies examine its effects on estrogen-dependent cell proliferation in MCF-7 breast cancer cultures, comparing inhibition patterns with anastrozole and letrozole controls. Bone metabolism research evaluates exemestane’s impact on osteoblast and osteoclast activity, particularly investigating paradoxical bone-protective effects despite estrogen suppression. Endocrinology laboratories study exemestane’s influence on gonadotropin feedback mechanisms and hypothalamic-pituitary-gonadal axis modulation. Aromatase inhibitor research protocols frequently incorporate exemestane for dose-response studies examining estrogen synthesis inhibition across various tissue types. Advanced studies investigate potential neuroprotective properties and cognitive effects through estrogen receptor pathway modulation. Comparative pharmacology research examines exemestane alongside selective androgen receptor modulators and research peptides for comprehensive hormonal pathway mapping.
Compound Specifications
| Parameter | Value |
|---|---|
| Chemical Name | 6-Methyleneandrosta-1,4-diene-3,17-dione |
| CAS Number | 107868-30-4 |
| Molecular Formula | C₂₀H₂₄O₂ |
| Molecular Weight | 296.40 g/mol |
| Purity | ≥98% (HPLC verified) |
| Form | Oral tablets |
| Concentration | 25mg per tablet |
| Storage | Room temperature, dry conditions |
Research Compliance Statement
Aromasin 25mg Para Pharma is manufactured exclusively for in-vitro laboratory research and experimental studies. This product is not intended for human consumption, therapeutic use, or any clinical application. Researchers must ensure appropriate laboratory safety protocols and institutional approval before conducting exemestane studies. All investigations should align with relevant research ethics guidelines and local regulations governing aromatase inhibitor research compounds.
